WEIGAO GROUP is potentially selling over 94% of Weigao Purui to exchange for Weigao Blood Purification A shares
WEIGAO GROUP (01066.HK) announced that on October 17, it signed a non-binding letter of intent, under which Weigao Blood Purification (603014.SH) intends to issue consideration shares to the company and Weihai Shengxi to acquire 100% equity of Weigao Purui. If realized, the group's overall business landscape will further expand.
Currently, the company holds 94.0706% equity of Weigao Purui, which focuses on the research, development, production, and sales of prefilled drug delivery systems and automatic safety drug delivery systems, committed to providing a one-stop drug delivery overall solution for global biopharmaceutical companies
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments